# Computational epitope heterogeneity analysis in immunostainings from antibody-dilution series

**Authors:** Dominik Tschimmel, Momina Saeed, Maria Milani, Steffen Waldherr, Tim Hucho

PMC · DOI: 10.1038/s42003-026-09517-x · 2026-02-02

## TL;DR

This paper introduces a computational method to analyze and improve antibody staining by studying epitope heterogeneity through dilution experiments.

## Contribution

A new computational approach to quantify epitope heterogeneity and optimize antibody dilutions for better staining and multiplexing.

## Key findings

- The method identifies optimal antibody dilutions to maximize signal specificity.
- It enables single-channel antibody multiplexing based on binding properties.
- The approach helps analyze binding targets of multi-specific antibodies.

## Abstract

Antibodies are widely used in life sciences and medical therapy. Broadly applicable methods to determine epitope heterogeneity in immunostaining systems are missing. Here, we present a simple-to-use approach to characterize and quantify antibody binding properties that constitute the staining directly in the system of choice. We determine an epitope heterogeneity on the basis of a computational analysis of antibody-dilution immunofluorescence stainings. This allows us to choose signal-specificity maximizing dilutions and to improve signal quantification. Furthermore, the computational analysis provides approaches to obtain a single-channel antibody multiplexing. Our approach could help improving immunostainings in many laboratories by guiding the choice of antibody dilution, by increasing the possibility of antibody-multiplexing in the same color-channel and by allowing for the analysis of binding targets of multi-specific antibodies.

Computational epitope heterogeneity analysis from simple dilution-series experiments can improve immunostaining in many laboratories. The analysis enables a computational single-color channel multiplexing based on binding properties.

## Full-text entities

- **Genes:** CTRL (chymotrypsin like) [NCBI Gene 1506] {aka CTRL1}, Uchl1 (ubiquitin carboxy-terminal hydrolase L1) [NCBI Gene 22223] {aka PGP 9.5, PGP9.5, UCH-L1, UCHL-1, gad}, Nefh (neurofilament, heavy polypeptide) [NCBI Gene 380684] {aka NF-H, NF200, Nfh, mKIAA0845}, PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha) [NCBI Gene 5576] {aka PKR2, PRKAR2}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, RPS11 (ribosomal protein S11) [NCBI Gene 6205] {aka S11, uS17}, Rps11 (ribosomal protein S11) [NCBI Gene 27207]
- **Chemicals:** CO2 (MESH:D002245), PFA (MESH:C003043), PBS (MESH:D007854), Tween 20 (MESH:D011136), DMSO (MESH:D004121), Alexa Fluor Plus 647 (-), penicillin (MESH:D010406), water (MESH:D014867), Hoechst 34580 (MESH:C572112), Alexa Fluor 555 (MESH:C000608607), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12902027/full.md

---
Source: https://tomesphere.com/paper/PMC12902027